Your browser doesn't support javascript.
loading
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group.
Zatelli, Maria Chiara; Faggiano, Antongiulio; Argentiero, Antonella; Danesi, Romano; D'Oronzo, Stella; Fogli, Stefano; Franchina, Tindara; Giorgino, Francesco; Marrano, Nicola; Giuffrida, Dario; Gori, Stefania; Marino, Giampiero; Mazzilli, Rossella; Monami, Matteo; Montagnani, Monica; Morviducci, Lelio; Natalicchio, Annalisa; Ragni, Alberto; Renzelli, Valerio; Russo, Antonio; Sciacca, Laura; Tuveri, Enzo; Aimaretti, Gianluca; Avogaro, Angelo; Candido, Riccardo; Di Maio, Massimo; Silvestris, Nicola; Gallo, Marco.
Afiliação
  • Zatelli MC; Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: ztlmch@unife.it.
  • Faggiano A; Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. Electronic address: antongiulio.faggiano@uniroma1.it.
  • Argentiero A; Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. Electronic address: argentieroantonella@gmail.com.
  • Danesi R; Oncology and Haematology Dept, University of Milano "La Statale", Milano, Italy. Electronic address: danesi.romano@gmail.com.
  • D'Oronzo S; Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy. Electronic address: stella.doronzo@uniba.it.
  • Fogli S; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: stefano.fogli@unipi.it.
  • Franchina T; Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy. Electronic address: tindara.franchina@unime.it.
  • Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. Electronic address: francesco.giorgino@uniba.it.
  • Marrano N; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. Electronic address: nicola.marrano@uniba.it.
  • Giuffrida D; Department of Oncology, Istituto Oncologico del Mediterraneo, Viagrande, Catania, Italy. Electronic address: dgiuff57@gmail.com.
  • Gori S; Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, Verona, Italy. Electronic address: stefania.gori@sacrocuore.it.
  • Marino G; Internal Medicine Department, Ospedale dei Castelli, Asl Roma 6, Ariccia, RM Italy. Electronic address: giampiero.marino@aslroma6.it.
  • Mazzilli R; Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. Electronic address: rossella.mazzilli@gmail.com.
  • Monami M; Diabetology, Careggi Hospital and University of Florence, Italy. Electronic address: matteo.monami@unifi.it.
  • Montagnani M; Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, University of Bari Aldo Moro, Bari, Italy. Electronic address: monica.montagnani@uniba.it.
  • Morviducci L; Diabetology and Nutrition Unit, Department of Medical Specialties, ASL Roma 1 - S. Spirito Hospital, Rome, Italy. Electronic address: leliomorviducci@gmail.com.
  • Natalicchio A; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. Electronic address: annalisa.natalicchio@uniba.it.
  • Ragni A; Endocrinology and Metabolic Diseases Unit, Azienda Ospedaliero-Universitaria SS Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy. Electronic address: alberto.ragni@ospedale.al.it.
  • Renzelli V; Diabetologist and Endocrinologist, Italian Association of Clinical Diabetologists, Rome, Italy. Electronic address: valerio.renzelli@gmail.com.
  • Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy. Electronic address: antonio.russo@usa.net.
  • Sciacca L; Department of Clinical and Experimental Medicine, Endocrinology Section, University of Catania Catania, Italy. Electronic address: laura.sciacca@unict.it.
  • Tuveri E; Diabetology, Endocrinology and Metabolic Diseases Service, ASL-Sulcis, Italy. Electronic address: enzo.tuveri@gmail.com.
  • Aimaretti G; Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. Electronic address: gianluca.aimaretti@med.uniupo.it.
  • Avogaro A; Department of Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, Padova, Italy. Electronic address: angelo.avogaro@unipd.it.
  • Candido R; Department of Medical Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy. Electronic address: riccardo.candido@yahoo.it.
  • Di Maio M; Department of Oncology, University of Turin, Turin, Italy. Electronic address: massimo.dimaio@unito.it.
  • Silvestris N; Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy. Electronic address: nicola.silvestris@unime.it.
  • Gallo M; Endocrinology and Metabolic Diseases Unit, Azienda Ospedaliero-Universitaria SS Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy. Electronic address: marco.gallo@ospedale.al.it.
Cancer Treat Rev ; 126: 102734, 2024 May.
Article em En | MEDLINE | ID: mdl-38604051
ABSTRACT
Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article